Aortic valve disease (AVD) and stable ischemic heart disease (SIHD) are two common cardiovascular conditions that can coexist and impact patient outcomes. AVD affects the aortic valve, which regulates blood flow from the left ventricle of the heart to the rest of the body. SIHD occurs when there is a reduced blood flow to the heart due to coronary artery disease (CAD). The incidence of AVD in patients with SIHD remains unclear, but studies suggest that it is not uncommon. The presence of both conditions can increase the risk of cardiovascular morbidity and mortality, especially in older adults. In addition, the presence of AVD in SIHD patients can complicate treatment decisions and impact outcomes. Patients with both conditions may be at higher risk of perioperative complications following coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) surgeries. For instance, the presence of AVD may impact the type of surgery recommended for SIHD patients, as well as the timing and sequence of the procedures. Therefore, careful assessment and management of both conditions are essential for optimizing outcomes in these patients. A multidisciplinary approach involving cardiologists, cardiac surgeons, and other healthcare professionals is necessary to evaluate and manage patients with coexisting AVD and SIHD. Diagnostic tests, such as echocardiography, can help identify the extent and severity of both conditions. Treatment options may include medications, lifestyle modifications, or surgical interventions. In conclusion, the co-occurrence of AVD and SIHD is an important clinical consideration that requires careful evaluation and management to optimize patient outcomes. Healthcare professionals must be aware of the potential complications and treatment implications of both conditions to provide the best care for these patients. Keywords: Aortic regurgitation, Aortic stenosis, Aortic sclerosis, Ischemic heart disease, Echocardiography.